1)- Megan E Spurgeon. Small DNA tumor viruses and human cancer: Preclinical models of virus infection and disease.Tumour virus research. 2022, 14: 200239
2)- Federica Inturrisi, Johannes A Bogaards, Albert G Siebers, Chris J L M Meijer, Daniëlle A M Heideman, Johannes Berkhof. Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later.Tumour virus research. 2022, 14: 200240
3)- Robert van der Geize, Natalie Methorst, Maarten Niemantsverdriet. Detection of high-risk HPV in FFPE specimens of various tumours using the BD Onclarity™ HPV Assay.Tumour virus research. 2022, 14: 200243
5)- Luisa Galati, Susanna Chiocca, Daria Duca, Marta Tagliabue, Cindy Simoens, Tarik Gheit, Marc Arbyn, Massimo Tommasino. HPV and head and neck cancers: Towards early diagnosis and prevention.Tumour virus research. 2022, 14: 200245
7)- Alexander Hesselberg Løvestad, Adina Repesa, Jean-Marc Costanzi, Sonja Lagström, Irene Kraus Christiansen, Trine B Rounge, Ole Herman Ambur. Differences in integration frequencies and APOBEC3 profiles of five high-risk HPV types adheres to phylogeny.Tumour virus research. 2022, 14: 200247
9)- Marwa Hassan, Mohammed Saad Attia, Zainab Ali-Eldin, Gamal El Attar, Mohamed Elzallat, Hany Haroun Kaisar Saad, Amira Isaac. Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients.Tumour virus research. 2022, 14: 200249